Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine for Thrombosis Prevention in Behcet's Disease
NCT04022421Unknown
- Sponsor
- Assiut University
- Start
- Oct 2018
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of hydroxychloroquine in Behcet's disease (BD) (2 arms), sponsored by Assiut University. Primary endpoint: Prevention of the recurrence of thrombotic events at 1 year. Status: unknown.
02
Drugs
hydroxychloroquine
03
Conditions
Behcet's disease (BD)
Beyond the preview
Go deeper on NCT04022421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04022421.